多omics分析显示,通过调节丰的新陈代谢,肠道微生物群的稳定性和线粒体Bax/Bcl-2通路,经典的可以缓解性结肠炎
Xujin Yang1, Shen Peng1, Ping Wang1
1College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China; Zhejiang Provincial Key Laboratory of TCM for Innovative R&D and Digital Intelligent Manufacturing of TCM Great Health Products, China.
Journal of pharmaceutical and biomedical analysis
|May 21, 2025
概括
格根廷脱剂 (GQD) 通过正常化肠道新陈代谢,平衡微生物群,减少肠道细胞亡,有效治疗性结肠炎 (UC). 这项研究确定了GQD.
科学领域:
- 传统中国医药 传统中国医药
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病,治疗选择有限.
- 传统中医药的 Gegen Qinlian Decoction (GQD) 在临床上用于UC,但其活性成分和机制尚未完全理解.
研究的目的:
- 为了确定GQD的活性成分.
- 阐明GQD在治疗UC中的药理机制.
- 研究GQD对UC的代谢学,肠道微生物群和亡途径的影响.
主要方法:
- 使用硫酸德克斯 (DSS) 诱导的UC小鼠模型.
- 通过临床,病理和血清学标记来评估GQD治疗效果.
- 进行了基于超高性能液体染色学四极管-轨道式质谱学 (UPLC-Q-Orbitrap MS) 的代谢学和肠道微生物群分析.
- 网络药理学,西部抹杀和ELISA测定被用来验证机制.
主要成果:
- GQD显著改善了UC症状和改善了病理状况.
- 确定了GQD的98种化学成分,在UC小鼠中调节22种差异性代谢物.
- GQD使酸,氨酸和氨酸的新陈代谢正常化,增强了有益的肠道细菌,并减少了促炎细胞因子.
- 网络药理学预测和实验证实了GQD对Bax/Bcl-2亡通路的下调.
结论:
- 在治疗UC时,GQD显示出显著的治疗效果.
- GQD通过调节关键代谢通路 (氨酸,氨酸,氨酸) 来缓解UC.
- GQD恢复了肠道微生物群的平衡,并减少了肠道细胞亡,提供了一种多目标治疗方法.
更多相关视频
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
290
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
290
Drugs for Treatment of Ulcerative Colitis in IBD
115
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
115


